ClinicalTrials.gov
public full text
Public Domain
Effects of Exendin(9-39) on Gastroduodenal Motility
The purpose of this study in humans is to define the effects of the endogenous hormone GLP-1 on gastroduodenal motility and on endocrine pancreatic secretion by using the specific GLP-1 receptor antagonist exendin(9-39). To elucidate possible cholinergic pathways, we combined exendin(9-39) with the muscarinergic antagonist atropine.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- GLP-1 Receptor Agonists and All-Cause Overdose Risk in Veterans With Type 2 Diabetes and Opioid Use Disorder.#631018
- Effect of Bile Acids on GLP-1 Secretion#272290
- Impact GLP-1 Agonists Following Bariatric#828178
- Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers#850347
- Eficacia y seguridad de los agonistas del receptor del péptido similar al glucagón tipo 1 (GLP-1RA) en prevención primaria de eventos cardiovasculares en pacientes con diabetes mellitus tipo 2 sin enfermedad cardiovascular establecida: una revisión sistemática y metaanálisis de ensayos clínicos aleatorizados#389752
Record · ID 993714
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive